Accessibility Tools

Slider-1 Slider-2 Slider-3 Slider-4 Slider-5 Slider-6

Andrew Storm MDInterview with
Dr. Andy Storm

Chief of Endoscopy,
Mayo Clinic, Rochester, MN

discussing future approach to weight loss options

News

We're excited to announce that Endo-TAGSS was recently selected to be part of the MedTech Innovator 2024 Accelerator program! – < Read More

MedTech Innovator selects Endo-TAGSS for its West Coast pitch event in March 2024. MedTech Innovator's mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system.

MAYO Clinic presented TAGSS ANTRAL GASTROPLASTY as the keynote address at ASGE DDW in May 2023.There was significant audience interest and questioning after the presentation was completed as noted by Dr. Storm.

Mayo Clinic Department of Gastroenterology presented a video utilizing TAGSS in animal studies and was selected for this year’s Digestive Disease Week 2021 ASGE Video Presentation with Honors.

Endo-TAGSS selected as one of the 5 finalists for this year’s Shark Tank Presentation at the AGA Virtual Tech Summit on April 29-30, 2021.

Endo-TAGSS participated in SAGES Shark Tank Competition 2021.

Currently Endo-TAGSS is performing TAGSS Fundoplication in animal studies at MAYO Clinic in Rochester MN.

 

TAGSS

A system and method for providing a novel trans-abdominal gastric access device for surgical instruments by means of a percutaneous abdominal-gastric cannula with internal bolster that is positioned endoscopically similar to a standard pull-through percutaneous endoscopic gastrostomy technique. 

TAGSS header2

Slider
 

CURRENT RESEARCH

Endo-TAGSS is currently actively involved in studies to address the burgeoning obesity epidemic, working with Dr. Andrew Storm and Dr. Barham K. Abu Dayyeh, MAYO Clinic Rochester MN. Preliminary studies show feasibility of TAGSS Antral Gastroplasty as a possible alternative to Endoscopic and Surgical Gastric Sleeve as well as Roux-n-Y Gastric Bypass.

Data using a porcine model was presented at DDW 2023. This innovative and disruptive technology can theoretically be accomplished in an out-patient setting and be safer, more cost effective and widely available than current treatments.